Novo Nordisk: Summer Figure in Focus – Prescriptions for Weight Loss Medications on the Rise

Novo Nordisk is a Danish pharmaceutical company that specializes in treating chronic diseases with a high medical need, particularly in the areas of diabetes, obesity, and rare metabolic disorders. The business model is based on the development and marketing of innovative biopharmaceuticals, with an increasing focus on GLP-1-based therapies that regulate blood sugar and enable significant weight loss. With blockbusters like Ozempic and Wegovy, Novo Nordisk has secured a leading market position in the globally fast-growing obesity market, benefiting...